The CB2 cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects
Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement
Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis- A role for A2A receptors
Cannabidiol Attenuates Cisplatin-Induced Nephrotoxicity by Decreasing Oxidative-Nitrosative Stress, Inflammation, and Cell Death
The effects of Δ9-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis
The CB2 cannabinoid receptor-selective agonist O-3223 reduces pain and inflammation without apparent cannabinoid behavioral effects